111 related articles for article (PubMed ID: 27595183)
1. Cost-effectiveness of initial antiretroviral treatment administered as single vs. multiple tablet regimens with the same or different components.
Llibre JM; de Lazzari E; Molina JM; Gallien S; Gonzalez-García J; Imaz A; Podzamczer D; Clotet B; Domingo P; Gatell JM
Enferm Infecc Microbiol Clin (Engl Ed); 2018 Jan; 36(1):16-20. PubMed ID: 27595183
[TBL] [Abstract][Full Text] [Related]
2. Uptake and virological outcomes of single- versus multi-tablet antiretroviral regimens among treatment-naïve youth in the HIV Research Network.
Griffith DC; Farmer C; Gebo KA; Berry SA; Aberg J; Moore RD; Gaur AH; Mathews WC; Beil R; Korthuis PT; Nijhawan AE; Rutstein RM; Agwu AL;
HIV Med; 2019 Feb; 20(2):169-174. PubMed ID: 30561888
[TBL] [Abstract][Full Text] [Related]
3. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
Scott Sutton S; Magagnoli J; Hardin JW
Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
[TBL] [Abstract][Full Text] [Related]
4. Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting.
Colombo GL; Castagna A; Di Matteo S; Galli L; Bruno G; Poli A; Salpietro S; Carbone A; Lazzarin A
Ther Clin Risk Manag; 2014; 10():9-15. PubMed ID: 24379676
[TBL] [Abstract][Full Text] [Related]
5. Comparison of adherence to generic multi-tablet regimens vs. brand multi-tablet and brand single-tablet regimens likely to incorporate generic antiretroviral drugs by breaking or not fixed-dose combinations in HIV-infected patients.
Rwagitinywa J; Lapeyre-Mestre M; Bourrel R; Montastruc JL; Sommet A
Fundam Clin Pharmacol; 2018 Aug; 32(4):450-458. PubMed ID: 29505661
[TBL] [Abstract][Full Text] [Related]
6. Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens.
Clay PG; Nag S; Graham CM; Narayanan S
Medicine (Baltimore); 2015 Oct; 94(42):e1677. PubMed ID: 26496277
[TBL] [Abstract][Full Text] [Related]
7. Adherence after treatment switch from a multiple tablet antiretroviral regimen to a single tablet antiretroviral regimen.
Sutton SS; Magagnoli J; H Cummings T; Hardin JW
Therapie; 2021; 76(6):567-576. PubMed ID: 33589316
[TBL] [Abstract][Full Text] [Related]
8. Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy.
Blanco JL; Montaner JS; Marconi VC; Santoro MM; Campos-Loza AE; Shafer RW; Miller MD; Paredes R; Harrigan R; Nguyen ML; Perno CF; Gonzalez-Hernandez LA; Gatell JM
AIDS; 2014 Nov; 28(17):2531-9. PubMed ID: 25574957
[TBL] [Abstract][Full Text] [Related]
9. Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy.
Sutton SS; Magagnoli J; Hardin JW
Pharmacotherapy; 2017 Feb; 37(2):204-213. PubMed ID: 28028855
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV.
Clay PG; Yuet WC; Moecklinghoff CH; Duchesne I; Tronczyński KL; Shah S; Shao D
AIDS Res Ther; 2018 Oct; 15(1):17. PubMed ID: 30373620
[TBL] [Abstract][Full Text] [Related]
11. Cumulative tenofovir diphosphate exposure in persons with HIV taking single- vs. multiple-tablet regimens.
Coyle RP; Morrow M; MaWhinney S; Coleman SS; Zheng JH; Ellison L; Bushman LR; Kiser JJ; Anderson PL; Castillo-Mancilla JR
Pharmacotherapy; 2022 Aug; 42(8):641-650. PubMed ID: 35707973
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults.
Pérez-Molina JA; Martínez E; Blasco AJ; Arribas JR; Domingo P; Iribarren JA; Knobel H; Lázaro P; López-Aldeguer J; Lozano F; Mariño A; Miró JM; Moreno S; Negredo E; Pulido F; Rubio R; Santos J; de la Torre J; Tuset M; von Wichmann MA; Gatell JM
Enferm Infecc Microbiol Clin (Engl Ed); 2019 Mar; 37(3):151-159. PubMed ID: 29884455
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between Single Tablet Antiretroviral Regimen and Adherence to Antiretroviral and Non-Antiretroviral Medications Among Veterans' Affairs Patients with Human Immunodeficiency Virus.
Yager J; Faragon J; McGuey L; Hoye-Simek A; Hecox Z; Sullivan S; Neubert S; Patel N
AIDS Patient Care STDS; 2017 Sep; 31(9):370-376. PubMed ID: 28771023
[TBL] [Abstract][Full Text] [Related]
14. Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries.
Cohen J; Beaubrun A; Bashyal R; Huang A; Li J; Baser O
AIDS Res Ther; 2020 Apr; 17(1):12. PubMed ID: 32238169
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Single- and Multiple-Tablet Antiretroviral Regimens in Correctional Setting for Treatment-Experienced HIV Patients.
Merker A; Badowski M; Chiampas T; Pérez SE; Patel M; Young J; Werner R
J Correct Health Care; 2018 Jan; 24(1):52-61. PubMed ID: 29239232
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported outcomes among people living with HIV on single- versus multi-tablet regimens: Data from a real-life setting.
Degroote S; Vandekerckhove L; Vogelaers D; Vanden Bulcke C
PLoS One; 2022; 17(1):e0262533. PubMed ID: 35025957
[TBL] [Abstract][Full Text] [Related]
17. Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Rivero A; Pérez-Molina JA; Blasco AJ; Arribas JR; Asensi V; Crespo M; Domingo P; Iribarren JA; Lázaro P; López-Aldeguer J; Lozano F; Martínez E; Moreno S; Palacios R; Pineda JA; Pulido F; Rubio R; Santos J; de la Torre J; Tuset M; Gatell JM
Enferm Infecc Microbiol Clin (Engl Ed); 2018 May; 36(5):268-276. PubMed ID: 28532596
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013].
Blasco AJ; Llibre JM; Arribas JR; Boix V; Clotet B; Domingo P; González-García J; Knobel H; López JC; Lozano F; Miró JM; Podzamczer D; Santamaría JM; Tuset M; Zamora L; Lázaro P; Gatell JM;
Enferm Infecc Microbiol Clin; 2013 Nov; 31(9):568-78. PubMed ID: 23969276
[TBL] [Abstract][Full Text] [Related]
19. Adherence among rural HIV-infected patients in the deep south: a comparison between single-tablet and multi-tablet once-daily regimens.
Tennant SJ; Hester EK; Caulder CR; Lu ZK; Bookstaver PB
J Int Assoc Provid AIDS Care; 2015; 14(1):64-71. PubMed ID: 25331217
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.
Cotte L; Ferry T; Pugliese P; Valantin MA; Allavena C; Cabié A; Poizot-Martin I; Rey D; Duvivier C; Cheret A; Dellamonica P; Pradat P; Parienti JJ;
PLoS One; 2017; 12(2):e0170661. PubMed ID: 28152047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
